61 results

• AFFF Lawsuit Alleges Camp Lejeune Water Contamination Caused Ulcerative Colitis

  July 14, 2022

  Irvin Jackson

  A new lawsuit claims Camp Lejeune water contamination caused a former U.S. Marine to develop ulcerative colitis.

• Study Finds Link Between Antibiotic Use and Inflammatory Bowel Diseases

  May 18, 2022

  Martha Garcia

  A new study links antibiotic use to an increased risk of IBD, particularly in elderly patients.

• Rinvoq Warning Label Updated to Add Cancer and Heart Risks Seen With Xeljanz Side Effects

  December 6, 2021

  Irvin Jackson

  Rinvoq will now carry label warnings on cancer and heart risks which were first discovered through a study of Xeljanz side effects.

• Eli Lilly-Funded Study Claims Side Effects of Olumiant Do Not Warrant Same Adverse Label Warnings as Xeljanz

  November 16, 2021

  Irvin Jackson

  A new study announced by Eli Lilly appears to suggest Olumiant, a rheumatoid arthritis drug, does not need the same label warnings for heart problems as Xeljanz, it's competitor.

• Xeljanz FDA Label Warning Update Adds Information About Risk of Cancer, Blood Clots and Heart Side Effects

  September 2, 2021

  Irvin Jackson

  The FDA is requiring new label warnings for Xeljanz and similar drugs, following a review which revealed links between increased risks of heart attacks, strokes, blood clots, and lymphomas, as well as an increased risk of lung cancer for current or former smokers.

• Ultra-Processed Food Consumption Could Increase Irritable Bowel Syndrome Risk: Study

  July 27, 2021

  Martha Garcia

  A new study links the consumption of ultra-processed foods to an increased risk of IBD.

• Side Effects of Stelara May Trigger Severe Cardiovascular Events: Study

  October 26, 2020

  Irvin Jackson

  A new study warns that Stelara can significantly increase the risk of heart problems and strokes among patients already at a high risk of coronary events.

• Probiotics Do Little To Help With Gut Health: Report

  June 18, 2020

  Martha Garcia

  Probiotics do little to help with gut health and are usually not worth the cost, according to guidelines in a new report.

• FDA Approves High-Dose, Extended-Release Version of Xeljanz, Despite Blood Clot Risks

  December 20, 2019

  Irvin Jackson

  The FDA has approved higher dose formulations of extended release Xeljanz, despite concerns over the risk of potentially fatal blood clots.

• Blood Clot Problems from Xeljanz Draw Updated EMA Warning for High Risk Patients

  November 5, 2019

  Irvin Jackson

  European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.